Tag: #Global Trends

A pharmaceutical company has announced that it secured tentative approval from the United States Food and Drug Administration (USFDA) for... Read more

In light of substantial recent investments in oncology and mounting competition, a leading pharmaceutical corporation is seeking a new approach... Read more

The U.S. Food and Drug Administration (FDA) has granted approval for the use of Durvalumab (an immunotherapy) in combination with... Read more

A pharmaceutical corporation has submitted a supplemental application for a higher dose semaglutide injectable (7.2 mg) to the U.S. Food... Read more

The recent decisions by a leading Swiss pharmaceutical group highlight a broader trend within the industry: prioritizing automation, advanced manufacturing... Read more

On November 24, 2025, in Basel, Sandoz, a global leader in affordable medicines, announced the European launch of Afqlir® (aflibercept).... Read more

The Sandoz group has officially introduced Afqlir, its biosimilar referencing aflibercept, across various European markets. The drug received approval from... Read more

The U.S. Food and Drug Administration (FDA) has approved the intrathecal (spinal injection) formulation of the gene therapy onasemnogene abeparvovec,... Read more

The pharmaceutical corporation AstraZeneca announced a plan to invest $2 billion to expand its production capabilities within the state of... Read more